ÂÜÀòÂÒÂ×

Sharon Hesterlee has an extensive background in the field of research and biopharmaceutical development, with experience at various organizations such as Muscular Dystrophy Association, Asklepios BioPharmaceutical, Inc., Pfizer, and Myotonic Dystrophy Foundation. Sharon holds a Ph.D. in Neuroscience from the University of Arizona and dual degrees in Zoology and Art from the University of Georgia. Sharon's expertise ranges from serving as EVP Chief Research Officer to VP Translational Research, showcasing their diverse skill set in scientific leadership and advocacy within the medical community.